Medicine News and Research

RSS

RTI Biologics launches BTB Select and BioCAP Select implants for use in sports medicine surgeries at AAOS 2010

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week.

11 Mar 2010

New study shows e-prescriptions reduce medication errors

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic prescriptions can dramatically reduce prescribing errors - up to seven-fold.

11 Mar 2010

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

At today's 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), two separate studies focus on the dramatic rise of pediatric sports injuries in recent years. However, despite this alarming trend, awareness, education, warning signs and early treatment can make a significant difference and help keep these athletes in the game, according to the study experts.

11 Mar 2010

Cytokeratins 8 and 18 can strongly enhance breast cancer drug fulvestrant's anti-estrogenic activity

Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy.

11 Mar 2010

FDA sponsoring workshops to increase rare disease treatment options

The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.

11 Mar 2010

Mayo Clinic to form new permanent professorship for cancer research

Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer.

11 Mar 2010

Clinical trial shows eprotirome drug reduces blood cholesterol

A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.

11 Mar 2010

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Cogent Healthcare today announced a new hospital medicine affiliation with 375-bed Seton Medical Center, located in Daly City, Calif., and the Daly City Hospitalist Medical Group, an existing Seton physician group, to develop a distinctive hospitalist care delivery system.

11 Mar 2010

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

10 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

Medical school costs, loan rates rise sharply

NPR reports on the high cost of medical school, focusing on one student, Sarah Rosen. The interest rate on her school loans "shot up to eight and a half percent, almost twice the rate [her parents] are paying after refinancing their mortgage."

10 Mar 2010

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.

10 Mar 2010

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Legislators need pork to make things happen, especially in an age when chronic obstruction has so weakened the legislative process that policy breakthroughs are almost impossible. This does not excuse all kinds of deal making, nor should we ignore that deals sometimes go too far (Julian E. Zelizer, 3/10).

10 Mar 2010

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.

10 Mar 2010

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Smith & Nephew's Endoscopy Division today announced the launch of the BIORAPTOR™ Knotless Suture Anchor, a device used to repair a torn labrum in the hip and shoulder. The anchor is among products featured at the American Academy of Orthopaedic Surgeons annual meeting, which began today in New Orleans.

10 Mar 2010

McGill University's Nurse Practitioner programs to be sponsored by Abbott

Today Abbott Laboratories announced it will sponsor McGill University's Nurse Practitioner programs launched by the McGill School of Nursing of the Faculty of Medicine. Over the last five years, the Nurse Practitioner programs have provided advanced training for registered nurses that enables them to assume additional responsibilities to provide enhanced patient care.

10 Mar 2010

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma.

10 Mar 2010

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.

10 Mar 2010

Springer to publish Nuclear Medicine and Molecular Imaging

NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.

10 Mar 2010

Inadvertent exposure of hospital housekeepers to drug-resistant "Superbugs" may lead to hospital-infection epidemic

One cause of the rampant international hospital-infection epidemic may be the "inadvertent exposure" of hospital housekeepers and transporters to antibiotic-resistant "Superbugs" such as MRSA, says TeleTracking Technologies CEO Anthony Sanzo.

10 Mar 2010

Medicine News and Research

RTI Biologics launches BTB Select and BioCAP Select implants for use in sports medicine surgeries at AAOS 2010

New study shows e-prescriptions reduce medication errors

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

Cytokeratins 8 and 18 can strongly enhance breast cancer drug fulvestrant's anti-estrogenic activity

FDA sponsoring workshops to increase rare disease treatment options

Mayo Clinic to form new permanent professorship for cancer research

Clinical trial shows eprotirome drug reduces blood cholesterol

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Small study shows eprotirome decreases LDL cholesterol

Medical school costs, loan rates rise sharply

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

McGill University's Nurse Practitioner programs to be sponsored by Abbott

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

Springer to publish Nuclear Medicine and Molecular Imaging

Inadvertent exposure of hospital housekeepers to drug-resistant "Superbugs" may lead to hospital-infection epidemic

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News